COVID-19: Insights into potential vaccines

Loo, Ke-Yan and Letchumanan, Vengadesh and Ser, Hooi-Leng and Teoh, Siew Li and Law, Jodi Woan-Fei and Tan, Loh Teng-Hern and Ab Mutalib, Nurul-Syakima and Chan, Kok-Gan and Lee, Learn-Han (2021) COVID-19: Insights into potential vaccines. Microorganisms, 9 (3). ISSN 2076-2607, DOI https://doi.org/10.3390/microorganisms9030605.

Full text not available from this repository.

Abstract

People around the world ushered in the new year 2021 with a fear of COVID-19, as family members have lost their loved ones to the disease. Millions of people have been infected, and the livelihood of many has been jeopardized due to the pandemic. Pharmaceutical companies are racing against time to develop an effective vaccine to protect against COVID-19. Researchers have developed various types of candidate vaccines with the release of the genetic sequence of the SARS-CoV-2 virus in January. These include inactivated viral vaccines, protein subunit vaccines, mRNA vaccines, and recombinant viral vector vaccines. To date, several vaccines have been authorized for emergency use and they have been administered in countries across the globe. Meanwhile, there are also vaccine candidates in Phase III clinical trials awaiting results and approval from authorities. These candidates have shown positive results in the previous stages of the trials, whereby they could induce an immune response with minimal side effects in the participants. This review aims to discuss the different vaccine platforms and the clinical trials of the candidate vaccines.

Item Type: Article
Funders: Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS)[MBRS/JCSMHS/02/2020], Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS)[PVC-ECR-2016]8813, Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS)[GBA-808138], Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS)[GBA-808813], University of Malaya Research Grant (FRGS grant)[FP022-2018A]
Uncontrolled Keywords: COVID-19;Coronavirus (CoV);Vaccines;Clinical trials;Passive immunotherapies
Subjects: Q Science > QR Microbiology
Q Science > QR Microbiology > QR355 Virology
R Medicine
T Technology > TP Chemical technology
Divisions: Faculty of Science
Depositing User: Ms Zaharah Ramly
Date Deposited: 22 Jun 2022 07:21
Last Modified: 22 Jun 2022 07:21
URI: http://eprints.um.edu.my/id/eprint/34222

Actions (login required)

View Item View Item